Crinetics Pharmaceuticals (CRNX) EBIT (2017 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly EBIT came in at -$140.4 million in Q1 2026, down 26.01% year-on-year from -$189.7 million in Q1 2025, and down 5.02% quarter-over-quarter from -$133.7 million in Q4 2025.
Crinetics Pharmaceuticals (CRNX) EBIT (2017 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' EBIT history runs 10 years deep, the most recent figure standing at -$140.4 million for Q1 2026.
- On a quarterly basis, EBIT fell 26.01% year-over-year to -$140.4 million in Q1 2026; TTM through Mar 2026 was -$545.7 million, a 44.86% decrease from a year earlier, with the FY2025 full-year figure at -$516.8 million, down 52.5% from the prior year.
- EBIT fell to -$140.4 million in Q1 2026 per CRNX's latest filing, from -$133.7 million in the prior quarter.
- Across five years, EBIT topped out at -$33.8 million in Q1 2022 and bottomed at -$142.6 million in Q3 2025.
- The 5-year median for EBIT is -$73.5 million (2024), against an average of -$81.6 million.
- Across the five-year window, EBIT tumbled 64.99% in 2022 and declined 23.12% in 2023, its largest moves.
- Year by year, EBIT stood at -$47.6 million in 2022, then tumbled by 31.76% to -$62.7 million in 2023, then tumbled by 51.21% to -$94.7 million in 2024, then tumbled by 41.08% to -$133.7 million in 2025, then dropped by 5.02% to -$140.4 million in 2026.
- Per Business Quant, the three latest CRNX EBIT figures stand at -$140.4 million (Q1 2026), -$133.7 million (Q4 2025), and -$142.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Crinetics Pharmaceuticals | 8.71 Bn | 8.71 Bn | 10.53 Mn | -140.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140.38 Mn |
| Dec 31, 2025 | -133.67 Mn |
| Sep 30, 2025 | -142.59 Mn |
| Jun 30, 2025 | -129.11 Mn |
| Mar 31, 2025 | -111.41 Mn |
| Dec 31, 2024 | -94.75 Mn |
| Sep 30, 2024 | -87.80 Mn |
| Jun 30, 2024 | -82.78 Mn |
| Mar 31, 2024 | -73.53 Mn |
| Dec 31, 2023 | -62.66 Mn |
| Sep 30, 2023 | -58.98 Mn |
| Jun 30, 2023 | -53.00 Mn |
| Mar 31, 2023 | -47.98 Mn |
| Dec 31, 2022 | -47.56 Mn |
| Sep 30, 2022 | -43.45 Mn |
| Jun 30, 2022 | -43.05 Mn |
| Mar 31, 2022 | -33.83 Mn |
| Dec 31, 2021 | -30.89 Mn |
| Sep 30, 2021 | -27.81 Mn |
| Jun 30, 2021 | -26.09 Mn |